Plasma from whole blood donations or apheresis is used to either prepare plasma components for clinical transfusion or fractionate to produce pure plasma proteins. Cryoprecipitate is produced by ...
By thawing INTERCEPT treated frozen plasma between 1° and 6° C and separating the precipitated cold-insoluble proteins and the supernatant, two distinct blood components are generated: pathogen ...
Two newer approaches to management of major hemorrhage missed the mark in randomized clinical trials published in a special transfusion-related issue of JAMA. In the CRYOSTAT-2 trial, adding early, ...
CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq:CERS) announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device designation for the Company’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results